Sonic Healthcare Limited
SHL
Rang in aandelen
#2845
Sonic Healthcare Limited delivers medical diagnostic services to a diverse... Sonic Healthcare Limited delivers medical diagnostic services to a diverse clientele, including medical professionals, hospitals, public health organizations, and individual patients. The company's services encompass a broad spectrum of laboratory medicine and pathology testing, covering biochemistry, cytopathology, genetics, haematology, histopathology, immunoserology, microbiology, molecular pathology, prenatal diagnostics, toxicology, and other related functions. Furthermore, Sonic provides extensive radiology services, such as magnetic resonance imaging (MRI), computed tomography (CT), ultrasound, X-ray, mammography, nuclear medicine, PET CT, interventional procedures, and bone mineral densitometry. Its offerings also extend to primary care medical services, featuring general practice clinics, occupational health, specialized skin cancer clinics, after-hours GP services, IT solutions for general practices, and various community-based healthcare programs. Operating internationally, the company has a significant presence in Australia, the United Kingdom, Ireland, the United States, Germany, Switzerland, New Zealand, and Belgium. Founded in 1934, Sonic Healthcare Limited is headquartered in Sydney, Australia.
Aandeelprijs
$13.26
Marktkapitalisatie
$6.55B
Verandering (1 dag)
-0.21%
Verandering (1 jaar)
-4.48%
Land
AU
Handel Sonic Healthcare Limited (SHL)
Categorie
Healthcare
Aantal uitstaande aandelen voor Sonic Healthcare Limited (SHL)
Aantal uitstaande aandelen per June 2026: 494.15M
Volgens de laatste financiële rapporten en de aandelenkoers van Sonic Healthcare Limited bedraagt het huidige aantal uitstaande aandelen 494.15M. Aan het einde van June 2024 had het bedrijf 476.10M uitstaande aandelen. Het aantal uitstaande aandelen wordt meestal beïnvloed door aandelensplitsingen en terugkoop van aandelen.
Geschiedenis van uitstaande aandelen van Sonic Healthcare Limited (SHL) van 2000 tot 2026
Uitstaande aandelen aan het einde van elk jaar
| Jaar | Uitstaande aandelen | Wijzigen |
|---|---|---|
| 2026 (TTM) | 494.15M | 2.66% |
| 2025 | 481.35M | 1.10% |
| 2024 | 476.10M | 1.35% |
| 2023 | 469.77M | -1.75% |
| 2022 | 478.14M | 0.16% |
| 2021 | 477.37M | 0.54% |
| 2020 | 474.83M | 5.80% |
| 2019 | 448.78M | 6.29% |
| 2018 | 422.21M | 1.32% |
| 2017 | 416.73M | 1.54% |
| 2016 | 410.41M | 2.24% |
| 2015 | 401.42M | 0.32% |
| 2014 | 400.13M | 1.32% |
| 2013 | 394.92M | 1.30% |
| 2012 | 389.84M | 0.36% |
| 2011 | 388.43M | 0.07% |
| 2010 | 388.14M | 6.23% |
| 2009 | 365.37M | 11.79% |
| 2008 | 326.85M | 9.96% |
| 2007 | 297.25M | 3.24% |
| 2006 | 287.91M | 5.88% |
| 2005 | 271.93M | 2.22% |
| 2004 | 266.02M | 2.54% |
| 2003 | 259.42M | 5.68% |
| 2002 | 245.47M | 21.00% |
| 2001 | 202.87M | 37.30% |
| 2000 | 147.75M | 0.00% |
Uitstaande aandelen van vergelijkbare bedrijven of concurrenten
| Bedrijf | Uitstaande aandelen | Verschil | Land |
|---|---|---|---|
| 371.00M | -24.92% |
US
|
|
| 705.30M | 42.73% |
US
|
|
| 143.28M | -71.00% |
US
|
|
| - | - |
CN
|
|
| 282.00M | -42.93% |
US
|
